bf/NYSE:AVNS_icon.jpeg

COM:AVANOS

Avanos Medical

  • Stock

USD

Last Close

18.02

22/11 21:00

Market Cap

890.08M

Beta: -

Volume Today

347.33K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
284.35M
-
293.15M
3.09%
287.85M
1.81%
181.80M
36.84%
106.25M
41.56%
133.65M
25.79%
157.40M
17.77%
159.60M
1.40%
170.30M
6.70%
176.75M
3.79%
average payables
143.60M
-
165.95M
15.56%
168.15M
1.33%
172.15M
2.38%
170.55M
0.93%
126.45M
25.86%
75.30M
40.45%
62M
17.66%
62.15M
0.24%
62.10M
0.08%
average receivables
218.60M
-
229.30M
4.89%
207.40M
9.55%
196.55M
5.23%
176.75M
10.07%
157.15M
11.09%
165.85M
5.54%
149.55M
9.83%
149.55M
0%
155.35M
3.88%
book value per share
32.04
-
22.65
29.31%
23.66
4.44%
25.97
9.77%
27.48
5.83%
26.58
3.29%
26.29
1.10%
26.28
0.04%
27.53
4.77%
26.53
3.64%
capex per share
-1.69
-
-1.51
10.41%
-0.62
58.68%
-0.92
47.82%
-1.04
12.69%
-1.06
2.19%
-0.42
60.25%
-0.44
3.31%
-0.41
5.74%
-0.38
7.18%
capex to depreciation
-0.92
-
-1.08
17.11%
-0.45
58.54%
-0.73
62.68%
-1.47
101.87%
-1.37
6.44%
-0.47
65.66%
-0.55
16.45%
-0.40
26.21%
-0.39
4.57%
capex to operating cash flow
-0.53
-
-0.72
35.90%
-0.15
78.63%
-0.30
94.37%
0.34
212.56%
0.68
101.41%
8.08
1,089.64%
-0.24
102.98%
-0.21
11.74%
-0.55
158.75%
capex to revenue
-0.05
-
-0.04
4.75%
-0.02
59.13%
-0.07
286.50%
-0.08
6.57%
-0.07
3.64%
-0.03
61.04%
-0.03
0.20%
-0.02
16.55%
-0.03
12.32%
cash per share
3.20
-
2.78
13.18%
2.44
12.23%
4.69
92.40%
8.15
73.53%
4.31
47.05%
2.33
45.92%
2.46
5.62%
2.72
10.52%
1.88
30.88%
days of inventory on hand
91.97
-
106.13
15.39%
96.15
9.40%
121.05
25.89%
169.51
40.04%
180.28
6.35%
180.52
0.14%
144.25
20.09%
187.73
30.14%
204.98
9.19%
days payables outstanding
54.81
-
57.12
4.23%
61.08
6.93%
227.48
272.42%
237.24
4.29%
102.56
56.77%
72.25
29.55%
54.13
25.08%
66.98
23.74%
70.71
5.57%
days sales outstanding
51.06
-
52.09
2.03%
43.58
16.35%
121.15
178.02%
84.21
30.49%
85.70
1.77%
85.74
0.04%
64.31
24.99%
74.74
16.21%
77.41
3.58%
debt to assets
0.25
-
0.29
14.83%
0.28
3.31%
0.26
5.34%
0.14
48.93%
0.18
33.84%
0.15
17.74%
0.12
20.94%
0.16
33.26%
0.11
31.82%
debt to equity
0.43
-
0.55
28.40%
0.53
4.13%
0.48
8.99%
0.19
60.05%
0.26
34.69%
0.20
23.01%
0.15
25.08%
0.22
46.18%
0.15
32.56%
dividend yield
0.32
-
earnings yield
0.01
-
-0.27
2,238.64%
0.02
108.43%
0.04
58.87%
0.03
25.87%
-0.03
205.20%
-0.01
56.65%
0.00
125.14%
0.04
1,176.10%
-0.06
248.59%
enterprise value
2.60B
-
2.01B
22.98%
2.19B
9.16%
2.52B
15.25%
1.98B
21.61%
1.72B
12.80%
2.33B
35.15%
1.74B
25.48%
1.42B
18.15%
1.17B
17.92%
enterprise value over ebitda
14.26
-
12.38
13.18%
14.29
15.43%
133.46
834.23%
47.30
64.56%
-142.50
401.24%
-1.17K
717.69%
36.64
103.14%
11.57
68.43%
11.84
2.41%
ev to operating cash flow
17.60
-
20.54
16.72%
11.59
43.57%
17.49
50.90%
-13.58
177.63%
-23.14
70.42%
-932.15
3,927.61%
19.89
102.13%
15.64
21.39%
36.01
130.27%
ev to sales
1.56
-
1.27
18.20%
1.37
7.93%
4.12
200.07%
3.03
26.50%
2.47
18.46%
3.26
31.90%
2.33
28.46%
1.73
25.68%
1.73
0.04%
free cash flow per share
1.49
-
0.58
60.85%
3.43
486.94%
2.16
37.03%
-4.13
291.14%
-2.63
36.29%
-0.47
81.93%
1.38
390.25%
1.53
10.76%
0.31
79.48%
free cash flow yield
0.03
-
0.02
46.72%
0.09
430.28%
0.05
49.57%
-0.09
297.07%
-0.08
15.32%
-0.01
86.73%
0.04
484.10%
0.06
41.91%
0.01
75.24%
graham net net
-12.26
-
-10.63
13.27%
-12.38
16.42%
-12.03
2.81%
0.46
103.85%
-2.80
704.25%
-1.98
29.46%
-0.80
59.32%
-3.13
289.87%
-3.86
23.09%
graham number
20.49
-
68.30
233.30%
21.32
68.78%
31.47
47.57%
27.45
12.77%
24.01
12.50%
18.35
23.61%
7.99
56.42%
25.83
223.04%
28.14
8.94%
income quality
5.46
-
-0.23
104.20%
4.74
2,171.97%
1.82
61.67%
-2.53
239.25%
1.62
164.10%
0.09
94.34%
16.79
18,165.85%
1.80
89.28%
-3.27
281.82%
intangibles to total assets
0.61
-
0.51
15.35%
0.58
12.61%
0.42
28.10%
0.52
24.78%
0.55
5.45%
0.57
4.85%
0.59
3.00%
0.60
1.32%
0.61
2.15%
interest coverage
15.72
-
-11.41
172.60%
2.67
123.42%
-1.36
151.03%
0.02
101.39%
-3.71
19,706.40%
-2.96
20.42%
2.70
191.26%
7.40
174.38%
3.49
52.79%
interest debt per share
13.80
-
13.12
4.93%
13.13
0.05%
13.09
0.30%
5.81
55.63%
7.15
23.14%
5.53
22.65%
3.97
28.29%
6.18
55.88%
4.20
32.05%
inventory turnover
3.97
-
3.44
13.34%
3.80
10.37%
3.02
20.56%
2.15
28.59%
2.02
5.97%
2.02
0.14%
2.53
25.14%
1.94
23.16%
1.78
8.42%
invested capital
0.43
-
0.55
28.40%
0.53
4.13%
0.48
8.99%
0.19
60.05%
0.26
34.69%
0.20
23.01%
0.15
25.08%
0.22
46.18%
0.15
32.56%
market cap
2.12B
-
1.56B
26.45%
1.72B
10.72%
2.16B
25.41%
2.11B
2.18%
1.60B
24.12%
2.19B
36.71%
1.67B
23.96%
1.27B
23.90%
1.05B
17.64%
net current asset value
-351.50M
-
-268.90M
23.50%
-375.80M
39.75%
180.20M
147.95%
177.40M
1.55%
4.10M
97.69%
50.90M
1,141.46%
87.90M
72.69%
4.10M
95.34%
30.90M
653.66%
net debt to ebitda
2.67
-
2.77
3.79%
3.04
9.68%
19.11
529.23%
-3.27
117.12%
-9.93
203.28%
-68.65
591.64%
1.46
102.12%
1.24
14.87%
1.23
0.54%
net income per share
0.58
-
-9.15
1,671.41%
0.85
109.33%
1.69
98.39%
1.22
28.11%
-0.96
179.16%
-0.57
40.99%
0.11
119.00%
1.08
896.00%
-1.33
223.16%
operating cash flow per share
3.18
-
2.10
34.08%
4.05
93.38%
3.08
23.95%
-3.08
200.12%
-1.57
49.26%
-0.05
96.66%
1.81
3,570.22%
1.94
6.79%
0.70
64.13%
payables turnover
6.66
-
6.39
4.05%
5.98
6.48%
1.60
73.15%
1.54
4.11%
3.56
131.32%
5.05
41.94%
6.74
33.48%
5.45
19.19%
5.16
5.28%
receivables turnover
7.15
-
7.01
1.99%
8.38
19.54%
3.01
64.03%
4.33
43.86%
4.26
1.74%
4.26
0.04%
5.68
33.31%
4.88
13.95%
4.71
3.46%
research and ddevelopement to revenue
0.02
-
0.02
2.10%
0.03
25.81%
0.06
141.98%
0.06
2.60%
0.05
15.67%
0.05
9.65%
0.04
11.15%
0.04
13.97%
0.04
8.26%
return on tangible assets
0.03
-
-0.44
1,706.71%
0.05
110.40%
0.06
35.65%
0.07
5.47%
-0.06
186.41%
-0.04
32.28%
0.01
120.90%
0.07
783.46%
-0.09
233.50%
revenue per share
35.93
-
33.80
5.94%
34.17
1.10%
13.07
61.75%
13.82
5.75%
14.66
6.05%
14.95
2.04%
15.48
3.52%
17.48
12.94%
14.45
17.36%
roe
0.02
-
-0.40
2,322.83%
0.04
108.94%
0.07
80.74%
0.04
32.06%
-0.04
181.85%
-0.02
40.33%
0.00
119.01%
0.04
850.62%
-0.05
227.81%
roic
0.01
-
-0.24
1,923.14%
0.04
115.58%
-0.01
128.52%
0.00
101.42%
-0.02
15,858.25%
-0.01
45.03%
0.01
140.16%
0.04
569.58%
0.05
28.30%
sales general and administrative to revenue
0.25
-
0.25
0.30%
0.26
2.00%
0.53
103.73%
0.52
0.79%
shareholders equity per share
32.04
-
22.65
29.31%
23.66
4.44%
25.97
9.77%
27.48
5.83%
26.58
3.29%
26.29
1.10%
26.28
0.04%
27.53
4.77%
26.53
3.64%
stock based compensation to revenue
0.00
-
0.01
89.56%
0.01
3.78%
0.02
121.65%
0.02
21.87%
0.02
6.49%
0.02
12.47%
0.02
4.72%
0.02
9.38%
0.02
21.02%
tangible asset value
-43.20M
-
27.50M
163.66%
-96.30M
450.18%
301.80M
413.40%
345.40M
14.45%
280M
18.93%
296.30M
5.82%
321.10M
8.37%
220.80M
31.24%
200.70M
9.10%
tangible book value per share
-0.93
-
0.59
163.59%
-2.07
450.07%
6.45
412.06%
7.32
13.48%
5.88
19.62%
6.20
5.38%
6.68
7.69%
4.71
29.48%
4.31
8.52%
working capital
328.90M
-
360.80M
9.70%
269.10M
25.42%
770.90M
186.47%
449.30M
41.72%
326M
27.44%
300.90M
7.70%
279.40M
7.15%
314M
12.38%
252.40M
19.62%

All numbers in USD (except ratios and percentages)